Stimulus Hopes Rise...
Abbott Laboratories (ABT: NYSE)
$60.22 -0.30 | -0.50%
06/04/12 - 04:02 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 6.81B | 3.65B | 8.81B | 4.11B |
| Receivables | 7.68B | 7.18B | 6.54B | 5.47B |
| Inventories | 3.28B | 3.19B | 3.26B | 2.78B |
| Other Current Assets | 0.00 | 1.87B | 1.21B | 1.26B |
| Total Current Assets | 23.77B | 22.32B | 23.31B | 17.04B |
| Property, Plant & Equipment, Gross | 18.02B | 17.37B | 16.49B | 15.19B |
| Accumulated Depreciation & Depletion | 10.14B | 9.40B | 8.87B | 7.97B |
| Property, Plant & Equipment, Net | 7.87B | 7.97B | 7.62B | 7.22B |
| Intangibles | 9.99B | 12.15B | 6.29B | 5.15B |
| Other Non-Current Assets | 378.22M | 302.05M | 1.13B | 1.07B |
| Total Non-Current Assets | 36.51B | 37.14B | 29.10B | 25.38B |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 60.28B | 59.46B | 52.42B | 42.42B |
| Accounts Payable | 1.72B | 1.54B | 1.28B | 1.35B |
| Short Term Debt | 3.37B | 6.39B | 5.19B | 2.73B |
| Other Current Liabilities | 1.27B | 1.99B | 1.10B | 2.28B |
| Total Current Liabilities | 15.48B | 17.26B | 13.05B | 11.59B |
| Long Term Debt | 12.04B | 12.52B | 11.27B | 8.71B |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 8.23B | 7.20B | 5.20B | 4.63B |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 20.36B | 19.81B | 16.51B | 13.35B |
| Total Liabilities | 35.84B | 37.07B | 29.56B | 24.94B |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 24.44B | 22.39B | 22.86B | 17.48B |
| Common Par | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Paid In Capital | 9.82B | 8.74B | 8.26B | 7.44B |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | 20.91B | 18.93B | 17.05B | 13.83B |
| Treasury Stock | -3.69B | -3.92B | -3.31B | -2.63B |
| Other Equity Adjustments | -2.60B | -1.37B | 854.07M | -1.16B |
| Total Capitalization | 36.48B | 34.91B | 34.12B | 26.19B |
| Total Equity | 24.44B | 22.39B | 22.86B | 17.48B |
| Total Liabilities & Stock Equity | 60.28B | 59.46B | 52.42B | 42.42B |
| Total Common Shares Outstanding | 1.57B | 1.55B | 1.55B | 1.55B |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 68.49M | 72.71M | 61.52M | 49.15M |
| Basic Weighted Shares Outstanding | 1.56B | 1.55B | 1.55B | 1.55B |
| Diluted Weighted Shares Outstanding | 1.57B | 1.56B | 1.55B | 1.56B |
| Number of Employees | 91000 | 90000 | 73000 | 69000 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ABT
- Portfolio NameUser Type
- ContributorRocket Stocks for the Week ...
- Contributor10 Best-Performing 'Dividen...
- Contributor3 Upcoming Spinoffs That Co...
- UserBen's Growth Dividend Stocks
- Userlj's Portfolio
- UserPerpetual growers
- UserEyeon
- UserStock
- Userdiz
- ContributorHighest-Yielding Drug Stocks
Latest ABT Headlines from TheStreet
- 5 Rocket Stocks to Buy in June 06.04.12 | 11:06 am
- 3 Stocks I Saw on TV, June 4
06.04.12 | 08:06 am - Cramer's 'Mad Money' Recap: Europe's Problems a Global Problem 06.01.12 | 07:06 pm
- Abbott Laboratories (ABT): Today's Featured Health Care Loser 06.01.12 | 05:06 pm
- Cramer's 'Mad Money' Recap: Avoid These High-Drama Stocks! 05.30.12 | 08:05 pm
- Cramer on Retirement: Individual Stocks Are Right for Your 401(k) 05.29.12 | 06:05 am
- Abbott Laboratories (ABT): Today's Featured Drugs Loser 05.23.12 | 05:05 pm
- Abbott Laboratories (ABT): Today's Featured Health Care Winner 05.16.12 | 04:05 pm
- Abbott Helps Big Pharma Look Even Worse 05.16.12 | 01:05 pm
- Abbott Laboratories (ABT): Today's Featured Health Care Loser 05.09.12 | 05:05 pm
Press Releases for ABT
- Abbott Again Recognized As One Of The 'Best Places To Work In Industry' By The Scientist Magazine - PR Newswire 06.01.12 | 09:06 am
- Absolute Software Partners With InComm To Sell LoJack For Laptops Through Major U.S. Retailers - PR Newswire 05.31.12 | 07:05 am
- Abbott To Present At Goldman Sachs 33rd Annual Global Healthcare Conference - PR Newswire 05.29.12 | 09:05 am
- Abbott To Present Wide Range Of Investigational Efficacy, Safety And Health Outcomes Data On HUMIRA® (Adalimumab) At The Annual Meeting Of The European League Against Rheumatism - PR Newswire 05.29.12 | 01:05 am
- Absolute Software Awarded Lenovo Top Supplier Award - PR Newswire 05.16.12 | 07:05 am
- Absolute Software Releases Turnkey BYOD Support For All Apple, Android And Windows Mobile Devices, Including Laptops - PR Newswire 05.15.12 | 08:05 am
- Abbott's XIENCE PRIME⢠And XIENCE V® Drug Eluting Stents Receive Indication In Europe For Minimum Three-Month Duration Of Dual Anti-Platelet Therapy - PR Newswire 05.15.12 | 08:05 am
- Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System With Insulin Calculator Now Available In Canada - PR Newswire 05.10.12 | 01:05 am
- Absolute Software Reaches Favourable Settlement Agreement In Precedent Setting Anti-Theft Patent Infringement Case - PR Newswire 05.08.12 | 06:05 pm
- Grant & Eisenhofer Represents Lead Whistleblower In Historic $1.6 Billion Settlement With Abbott Laboratories Over Off-Label Marketing Of Antiepileptic Medication Depakote - PR Newswire 05.07.12 | 02:05 pm
Partner Headlines for ABT
- Healthcare Business Recap: Dendreon BOMBS, Cancer Cures Galore - Wall St. Cheat Sheet 06.04.12 | 06:06 am
- Watchdog: Cramer Tells Investors Buy These 5 Stocks Now! - Wall St. Cheat Sheet 05.31.12 | 09:05 am
- 5 Strong Companies That Increased Yields By More Than 10% Over The Past 3 Years - Seeking Alpha 05.30.12 | 09:05 am
- Mason Hawkins' Southeastern Discusses Abbott Labs - GuruFocus 05.23.12 | 04:05 pm
- Zacks' Voice of the People highlights opportunities with Johnson & Johnson, Disney, Abbott Labs and Church & Dwight - Press Releases - Zacks 05.23.12 | 09:05 am
- Health Care SPDR In Focus Ahead Of Obamacare Decision - Benzinga 05.22.12 | 12:05 pm
- Auxilium-Glaxo to Drive Testim Sales - Analyst Blog - Zacks 05.22.12 | 10:05 am
- Big-Cap Leaders Bland, But Their Charts Holding Up - Investor's Business Daily 05.21.12 | 07:05 pm
- The Definitive Biotech ETF Guide (IBB, XBI, FBT) - Benzinga 05.21.12 | 01:05 pm
- Medgenics Moving In Record Time - Seeking Alpha 05.21.12 | 09:05 am





